JPH04104761A - Preparation of functional fermented milk and functional lactobacillus drink - Google Patents
Preparation of functional fermented milk and functional lactobacillus drinkInfo
- Publication number
- JPH04104761A JPH04104761A JP2221643A JP22164390A JPH04104761A JP H04104761 A JPH04104761 A JP H04104761A JP 2221643 A JP2221643 A JP 2221643A JP 22164390 A JP22164390 A JP 22164390A JP H04104761 A JPH04104761 A JP H04104761A
- Authority
- JP
- Japan
- Prior art keywords
- milk
- lactic acid
- lactobacillus
- fermented milk
- kpb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015140 cultured milk Nutrition 0.000 title claims abstract description 31
- 241000186660 Lactobacillus Species 0.000 title abstract description 3
- 229940039696 lactobacillus Drugs 0.000 title abstract description 3
- 150000004676 glycans Chemical class 0.000 claims abstract description 23
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 23
- 239000005017 polysaccharide Substances 0.000 claims abstract description 23
- SERLAGPUMNYUCK-URHLDCCQSA-N (2R,3S,4R,5S)-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,4,5-pentol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-URHLDCCQSA-N 0.000 claims abstract description 20
- 229920001755 Kefiran Polymers 0.000 claims abstract description 20
- 239000005862 Whey Substances 0.000 claims abstract description 16
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 16
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 16
- 241000186610 Lactobacillus sp. Species 0.000 claims abstract description 8
- 235000020244 animal milk Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 4
- 235000015192 vegetable juice Nutrition 0.000 claims abstract description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 74
- 241000894006 Bacteria Species 0.000 claims description 40
- 235000014655 lactic acid Nutrition 0.000 claims description 37
- 239000004310 lactic acid Substances 0.000 claims description 36
- 238000004519 manufacturing process Methods 0.000 claims description 18
- 235000013361 beverage Nutrition 0.000 claims description 10
- 239000008267 milk Substances 0.000 abstract description 5
- 210000004080 milk Anatomy 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 235000013336 milk Nutrition 0.000 abstract description 4
- 238000012258 culturing Methods 0.000 abstract description 2
- 238000000855 fermentation Methods 0.000 description 30
- 230000004151 fermentation Effects 0.000 description 29
- 235000015141 kefir Nutrition 0.000 description 17
- 239000007789 gas Substances 0.000 description 11
- 238000000926 separation method Methods 0.000 description 9
- 230000012010 growth Effects 0.000 description 8
- 229940035901 lactobacillus sp Drugs 0.000 description 8
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 230000001766 physiological effect Effects 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000008821 health effect Effects 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 235000020185 raw untreated milk Nutrition 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 2
- 235000020251 goat milk Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- -1 locust Bingham Polymers 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- WQMLFJWIKARBFW-BKKMTDGVSA-N evomonoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@H](CC[C@H]2[C@]3(CC[C@@H]([C@@]3(C)CC[C@H]32)C=2COC(=O)C=2)O)[C@]3(C)CC1 WQMLFJWIKARBFW-BKKMTDGVSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Dairy Products (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は莢膜多糖生産菌であるラグトバチルスsp、K
PB−167を利用した消化機能の昂進、抗腫瘍等の機
能性を有する発酵乳並びに乳酸菌飲料の製法に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention is directed to the use of capsular polysaccharide producing bacteria, Lugtobacillus sp, K.
The present invention relates to a method for producing fermented milk and lactic acid bacteria beverages that use PB-167 to enhance digestive function, have antitumor properties, and other functionalities.
[従来の技術]
発酵乳ケフィール(Kefir、ケフィアともいう)は
長寿者の多いことで知られるソ連コーカサス地方の伝統
的な発酵乳であり、健康食品としてソ連を含む東欧諸国
で盛んに製造されている。ケフィールは、ケフィール粒
と呼ばれるスタータを用いて製造されるが、ケフィール
粒は乳酸菌や酵母が共生した画境であり、莢膜多糖生産
乳酸菌が生産する莢膜多糖(ケフィラン)を支持体とし
ている。この莢膜多糖生産菌が生産するケフィランは、
ケフィール粒から熱抽出などにより得られ、抗腫瘍活性
などの優れた生理活性を持つことが知られている(特開
昭52−128207号、特公昭56−409号、特開
昭56−410号公報)。しがし、ケフィール粒は種々
の微生物相から構成されており、莢膜多糖ケフィランを
生産する菌の分離が困難であり、莢膜多糖ケフィランを
生産できる乳酸菌は利用されていなかった。[Prior art] Fermented milk kefir (also called kefir) is a traditional fermented milk from the Caucasus region of the Soviet Union, which is known for its long lifespan, and is actively produced in Eastern European countries including the Soviet Union as a health food. There is. Kefir is manufactured using a starter called kefir grain, which is a symbiotic border of lactic acid bacteria and yeast, and uses capsular polysaccharide (kefiran) produced by capsular polysaccharide-producing lactic acid bacteria as a support. Kefiran produced by this capsular polysaccharide producing bacterium is
It is obtained from kefir grains by heat extraction, etc., and is known to have excellent physiological activities such as antitumor activity (JP-A-52-128207, JP-A-56-409, JP-A-56-410). Public bulletin). However, kefir grains are composed of various microflora, and it is difficult to isolate the bacteria that produce capsular polysaccharide kefiran, and lactic acid bacteria that can produce capsular polysaccharide kefiran have not been used.
本発明者らは先にケフィール粒から莢膜多糖ケフィラン
を生産する乳酸菌の新株ラクトバチルスsp、KPB−
167を分離し、微工研菌寄第9886号(FERMP
−9886)として寄託し、この菌株を培養して莢膜多
糖を生産する方法を発明した、 (特願昭63−175
637)。The present inventors previously reported that a new strain of lactic acid bacteria, Lactobacillus sp., KPB-
167 was isolated and published in FERMP No. 9886 (FERMP
-9886), and invented a method for culturing this strain to produce capsular polysaccharide.
637).
[発明が解決しようとする課題]
上記生理活性を有するケフィランを食品特に発酵乳又は
乳酸菌飲料を製造するには、ケフィール粒をスタータと
して発酵させるか、ケフィール粒からケフィランを抽出
して、別途他の乳酸菌で発酵させた発酵乳、乳酸菌飲料
に添加するなとの方法しかなかった。前者の方法は、ケ
フィール忙中には莢膜多糖生産菌以外の多糖を生産でき
ない種々の乳酸菌や種々の酵母が混在しているため、ケ
フィランを効率よく生産することは困難であると共に、
品質の一定したものを製造することは不可能であった。[Problems to be Solved by the Invention] In order to produce foods, particularly fermented milk or lactic acid bacteria drinks, from the physiologically active kefiran described above, kefir grains are used as a starter to ferment the kefir grains, or kefir grains are extracted from the kefir grains, and then other The only option available was to not add it to fermented milk fermented with lactic acid bacteria or to lactic acid bacteria drinks. In the former method, it is difficult to efficiently produce kefiran because various lactic acid bacteria and various yeasts that cannot produce polysaccharides other than capsular polysaccharide-producing bacteria coexist in kefir production.
It was impossible to manufacture products with consistent quality.
また後者の方法は、ケフィール粒からケフィランを抽呂
するのに手間と時間並びに費用がか)るため工業上の採
用が困難であった。Furthermore, the latter method has been difficult to adopt industrially because it takes time, effort, and cost to extract kefiran from kefir grains.
また、一般に発酵乳を製造する場合に、乳酸発酵により
ホエー分離が起こり、製品上の欠陥となるため、粘質材
としてカラギーナン、寒天、ゼラチン、ローカストビン
ガム、グアーガム、スターチ等を添加して均質化を行っ
て、ホエー分離を防止しているが、これら粘質材の添加
のない発酵乳即ちホエー分離のない発酵乳の製法が要望
されている。In addition, when producing fermented milk, whey separation occurs due to lactic acid fermentation, which causes defects in the product, so carrageenan, agar, gelatin, locust Bingham, guar gum, starch, etc. are added as sticky materials to homogenize the product. However, there is a need for a method for producing fermented milk without the addition of these sticky materials, that is, a method for producing fermented milk without whey separation.
〔課題を解決するための手段]
本発明者らは上記課題を解決する目的で鋭意研究の結果
、先に本発明者が始めてケフィールグレインから分離し
た菌株ラクトバチルスsp、KPB−167(微工研菌
寄第9886号)を用い通常の発酵乳、乳酸菌飲料の製
法により発酵乳及び乳酸菌飲料を製造したところ、ケフ
ィールグレインが生産する消化機能の昂進作用、抗腫瘍
作用等の生理活性作用を有する莢膜多糖類を有し、しか
も製造させた発酵乳は乳酸発酵によるホエー分離が生ず
ることのない製法を見出し本発明を完成した。[Means for Solving the Problems] As a result of intensive research for the purpose of solving the above problems, the present inventors discovered that Lactobacillus sp, KPB-167, which the present inventors had first isolated from kefir grains, When fermented milk and lactic acid bacteria beverages were produced using the conventional method for producing fermented milk and lactic acid bacteria drinks, the pods produced by kefir grains had physiologically active effects such as enhancing digestive function and antitumor activity. The present invention was accomplished by finding a method for producing fermented milk that contains membrane polysaccharides and that does not cause whey separation due to lactic acid fermentation.
本発明は、発酵乳及び乳酸菌飲料の製造において、乳酸
菌として莢膜多糖生産菌ラクトバチルスsp、 KPB
−167を使用することを特徴とする機能性発酵乳及び
機能性乳酸菌飲料である。The present invention uses capsular polysaccharide producing bacteria Lactobacillus sp, KPB as lactic acid bacteria in the production of fermented milk and lactic acid bacteria beverages.
This is a functional fermented milk and a functional lactic acid bacteria drink characterized by using -167.
本発明に使用するラクトバチルスsp、KPB167株
は微工研菌寄第9886号として寄託された菌株で、ケ
フィール粒から分離されるラクトバチルス属に属する長
桿菌の一種で、その菌学的性質は次の通りである。Lactobacillus sp, strain KPB167, used in the present invention is a strain deposited as FIKEN Bacteria No. 9886, and is a type of long bacillus belonging to the genus Lactobacillus isolated from kefir grains, and its mycological properties are It is as follows.
A、菌の形態
(1) 細胞の大きさ、1〜1.5X15〜60(μ
m)(2)形 状:桿 状
(3) 運 動 性 な しく4)胞子の
有無:な し
く5)ダラム染色 陽 性
B、培地における生育状態
ミルグホエー寒天培地に菌を塗抹し、30℃で1週間嫌
気培養(ガスバック法又はグローブボックス法)した時
のコロニーの形態
培地組成
ミルクホエー8
ラグドース
カザミノ酸
L−システィン塩酸塩
酢酸ナトリウム
ツイーン 80*8
ミネラル B**8
寒天
H
00m12
g
o、5g
0.05g
0.5g
O,1g
i
g
5.5
*10%脱脂乳を乳酸でpH4,6とし、30分煮沸後
、沈殿を濾別した液。A. Bacterial morphology (1) Cell size, 1-1.5X15-60 (μ
m) (2) Shape: Rod-shaped (3) Motility: None 4) Presence of spores: None 5) Durham staining positive B, Growth status in medium Bacteria were smeared on Milg whey agar medium and incubated at 30°C. Colony morphology after 1 week of anaerobic culture (gas bag method or glove box method) Medium composition Milk whey 8 Ragdose Casamino acid L-cystine hydrochloride Sodium acetate Tween 80*8 Mineral B**8 Agar H 00m12 g o, 5g 0.05g 0.5g O, 1g i g 5.5 *10% skim milk was adjusted to pH 4.6 with lactic acid, boiled for 30 minutes, and the precipitate was filtered off.
零*ポリオキシエチレンソルビタンモノオレートの商品
名。Zero*Product name of polyoxyethylene sorbitan monooleate.
本本本組成: MgSO4・7H1O
MnSO4・4H,0
FeSO,・7H,O
aCQ
蒸留水
g
0、15 g
0、18 g
0.1g
100=
コロニーの性状
形状三田 形
大きさ:2〜4M
隆起:凸円状
周縁三田 滑
表面:円 滑
C0生理学的性質
■生育温度=30℃(至適)、20〜35℃(生育範囲
)■生育pl(+5.5〜6(至適)、5〜7.5(生
育範囲)■酸素に対する態度:通気嫌気性、好気下でも
生育するが、CO1存在下の方が生育良好。This composition: MgSO4・7H1O MnSO4・4H,0 FeSO,・7H,O aCQ Distilled water g 0, 15 g 0, 18 g 0.1 g 100 = Colony properties and shapes Mita Shape size: 2-4M Protuberance: Convex Circular periphery Mita Smooth surface: Smooth C0 Physiological properties ■ Growth temperature = 30°C (optimal), 20-35°C (growth range) ■ Growth pl (+5.5-6 (optimal), 5-7. 5 (Growth range) ■Attitude towards oxygen: Grows under aerobic and anaerobic conditions, but grows better in the presence of CO1.
■色素の生成:なし
■カタラーゼ:陰性
■糖からの生成乳酸の旋光性:D(L)型色調:白 色
透明度:半透明
硬度:粘 稠
構 造:均質、露滴状
■糖類からの酸及びガスの生成:
酸の生成 ガスの生成
り−(−)−アラビノノース
D−(+)−キシロノース
α−L−ラムノース
研リボース
ゲルコース
トマンノース
D(−)−フラクトース
トガラクトース
シュクロース
マルトース
セロビオース
ラクトース
トレハロース
メルビオース
ラフィノース
メレチトース
トマンニトール
トソルビトール
+
(19)エスクリン
(20)サリシン
(21)アミグダリン
本発明は上記菌株を一般の発酵乳及び乳酸菌飲料の乳酸
菌を使用する場合と同様にして発酵乳及び乳酸菌飲料を
製造することができる。■Pigment formation: None ■Catalase: Negative ■Optical rotation of lactic acid produced from sugars: D (L) type Color tone: White Color transparency: Transparent Hardness: Viscous Structure: Homogeneous, dewdrop-like ■Acid from sugars and gas production: Acid production Gas production -(-)-arabinonose D-(+)-xylonose α-L-rhamnose lab ribose gel coast mannose D(-)-fructose galactose sucrose maltose cellobiose lactose trehalose melubi Ausraffinose meletide toast mannitol to sorbitol + (19) esculin (20) salicin (21) amygdalin The present invention produces fermented milk and lactic acid bacteria beverages by using the above-mentioned bacterial strains in the same manner as in the case of using lactic acid bacteria for general fermented milk and lactic acid bacteria drinks. can be manufactured.
発酵乳の製法においては原料として、牛乳、山羊乳等の
獣乳、その脱脂乳等を使用する。In the method for producing fermented milk, animal milk such as cow's milk and goat's milk, skim milk thereof, etc. are used as raw materials.
原料乳は適度の濃度に濃縮または希釈して調製した後に
、常法により殺菌して使用する。The raw milk is concentrated or diluted to an appropriate concentration and then sterilized and used by conventional methods.
たとえば90℃で30分あるいは95℃で5分の加熱で
殺菌したり、さらに高い温度で短時間殺菌しても差し支
えない。殺菌後、無菌的に乳酸発酵に適した発酵温度に
まで冷却し、種菌としてラクトバチルスsp、KPB−
167を接種して発酵を行う。種菌の接種濃度は原料乳
の種類や濃度によっても異なるが、例えば0.5〜5%
(V/V)好ましくは1〜2%(V/V)程度接種する
。発酵は20〜45℃2好ましくは25〜30℃の温度
で20〜100時間程度行うと、培地中に乳酸が充分生
成して来ると共に、原料乳が半固形状となり、更に特徴
的なのは莢膜多糖生産菌の増殖に伴って多糖ケフイラン
が蓄積して来るため発酵乳が糸を引くような粘性をおび
て来る。発酵中は、ケフイラン生産菌の生育を促進する
ために気相部をCO,ガスで置換する方が好ましく、ま
た発酵中混合状態を良好にするために撹拌を行う方が好
ましい。For example, it may be sterilized by heating at 90°C for 30 minutes or 95°C for 5 minutes, or it may be sterilized at an even higher temperature for a short time. After sterilization, it is aseptically cooled to a fermentation temperature suitable for lactic acid fermentation, and Lactobacillus sp, KPB-
167 and fermentation is carried out. The inoculum concentration varies depending on the type and concentration of the raw milk, but for example, it is 0.5 to 5%.
(V/V) Preferably about 1 to 2% (V/V) is inoculated. When fermentation is carried out at a temperature of 20 to 45°C, preferably 25 to 30°C, for about 20 to 100 hours, lactic acid will be sufficiently produced in the medium and the raw milk will become semi-solid, and what is more characteristic is that capsules will form. As the polysaccharide-producing bacteria proliferate, the polysaccharide kefiran accumulates, resulting in fermented milk becoming stringy and viscous. During fermentation, it is preferable to replace the gas phase with CO or gas in order to promote the growth of kefiran-producing bacteria, and it is also preferable to perform stirring to improve the mixing state during fermentation.
発酵終了後の発酵乳は、抗腫瘍活性等の生理活性を持つ
莢膜多糖ケフィランを含有するため保健医療効果が期待
されると共に、粘性が有るためホエー分離を伴う二とが
無く、常に均質化された性状を示す新規な機能性発酵乳
・どなる。尚、発酵乳を作る際に、または発酵後に、フ
ルーツの香りのする添加物や果汁等を加えて風味を付け
たり、発酵の種菌中に風味成分を生産する乳酸菌等を適
量加えて発酵させて風味をつけることもできる。Fermented milk after fermentation is expected to have health and medical effects because it contains the capsular polysaccharide kefiran, which has physiological activities such as antitumor activity, and because it is viscous, there is no need for whey separation, and it is constantly homogenized. A new functional fermented milk with improved properties. In addition, when making fermented milk or after fermentation, add flavor by adding fruit-scented additives or fruit juice, or add an appropriate amount of lactic acid bacteria that produce flavor components to the fermentation starter. It can also be flavored.
乳酸菌飲料の製造法は、例えば牛乳、山羊乳等の獣乳か
ら得られるホエーや、チーズやバター製造時に副産物と
して出て来るホエー更には果汁、野菜ジュース等を原料
として使用する。必要であればラクトース、シュクロー
ス、グルコース等の糖源や栄養分を添加して種菌の生育
を促進させても差し支えない。The method for producing lactic acid bacteria beverages uses, for example, whey obtained from animal milk such as cow's milk or goat's milk, whey produced as a byproduct during the production of cheese or butter, as well as fruit juice, vegetable juice, etc. as raw materials. If necessary, a sugar source such as lactose, sucrose, or glucose or nutrients may be added to promote the growth of the inoculum.
原料は常法通りに殺菌した後、無菌的に乳酸発酵に適し
た温度にまで冷却し、種菌としてラクトバチルスsp、
KPB−167を接種して発酵させる。種苗接種量は原
料によっても異なるが、0.5〜5%(V/V)好まし
くは1〜2%(V/V)程度接種である。発酵温度は2
0〜45℃、好ましくは25〜30℃の温度で、20〜
100時間程度発酵させると、培地中に乳酸が生成する
と共にケフイランが蓄積し発酵液が粘性を示す様になる
。発酵中は、ケフイラン生産菌の生育促進のために気相
部をCO,ガスで置換する方が好ましい。発酵終了時に
風味成分を添加したり、発酵種菌中に風味成分を生産す
る乳酸菌等を適量加えて発酵させて風味を付加すること
もできる。発酵後の発酵液中には抗腫瘍活性等の生理活
性を持つ莢膜多糖ケフィランが含まれるため保健医療効
果を持つ新規の機能性乳酸菌飲料となる。After sterilizing the raw materials in a conventional manner, they were aseptically cooled to a temperature suitable for lactic acid fermentation, and Lactobacillus sp.
KPB-167 is inoculated and fermented. The amount of seedlings inoculated varies depending on the raw material, but is approximately 0.5 to 5% (V/V), preferably 1 to 2% (V/V). Fermentation temperature is 2
At a temperature of 0-45°C, preferably 25-30°C, 20-45°C
After fermentation for about 100 hours, lactic acid is produced in the medium and kefiran accumulates, and the fermented liquid becomes viscous. During fermentation, it is preferable to replace the gas phase with CO or gas in order to promote the growth of kefiran-producing bacteria. It is also possible to add a flavor component at the end of fermentation, or add an appropriate amount of lactic acid bacteria or the like that produces a flavor component to the fermentation starter and ferment it to add flavor. The fermented liquid after fermentation contains capsular polysaccharide kefiran, which has physiological activities such as antitumor activity, resulting in a novel functional lactic acid bacteria beverage with health and medical effects.
尚、本発明に使用するラクトバチルスsp。In addition, Lactobacillus sp used in the present invention.
KPB−167は永年飲用されて来たケフィールのスタ
ータとして使用されてきたケフィール粒から分離された
ものであり、当然のことながら菌は毒性が無く安全であ
り、本発明で製造される機能性発酵乳、乳酸菌飲料も当
然のことながら無害で安全である。KPB-167 is isolated from kefir grains that have been used as a starter for kefir that has been drunk for many years, and naturally the bacteria are non-toxic and safe, and the functional fermentation produced by the present invention. Milk and lactic acid bacteria drinks are naturally harmless and safe.
[実施例]
次に本発明の実施例を挙げるが、本発明はこの製法に限
定されるものではない。[Example] Next, examples of the present invention will be described, but the present invention is not limited to this manufacturing method.
例 1.(発酵乳)
脱脂粉乳200gを水1800m12に溶解した後、9
5℃で5分間加熱殺菌した。次に30℃に冷却した後、
ラクトバチルスsp、KPB−167の培養液40dを
接種し、30℃で72時間発酵した。発酵は、菌接種後
に気相部をCO,ガスで置換して嫌気的条件下で撹拌し
ながら行った。発酵経過中に発酵液を少量採取して粘性
およびホエーの分離状況を観察した。発酵後は、発酵乳
を透明ガラス容器に入れて約5℃の冷蔵庫中に保存し、
保存期間中の粘性およびホエー分離状況を観察した。そ
の結果を、第1表に示す。対照として、種菌にラクトバ
チルス・ブルガリカスを用いたものも示した。その結果
、ラクトバチルスsp、KPB−167を種菌とした場
合には発酵と共に粘性が増加すると共に、ホエー分離は
全く見られず、更に冷蔵保存中も全く粘性の低下やホエ
ー分離は起こらなかった。Example 1. (Fermented milk) After dissolving 200g of skim milk powder in 1800ml of water,
Heat sterilization was performed at 5°C for 5 minutes. Next, after cooling to 30°C,
40 d of culture solution of Lactobacillus sp, KPB-167 was inoculated and fermented at 30°C for 72 hours. Fermentation was carried out under anaerobic conditions with stirring, replacing the gas phase with CO and gas after inoculating the bacteria. During the course of fermentation, a small amount of the fermentation liquor was sampled and the viscosity and whey separation status were observed. After fermentation, put the fermented milk in a transparent glass container and store it in the refrigerator at about 5℃.
The viscosity and whey separation status during the storage period were observed. The results are shown in Table 1. As a control, a sample using Lactobacillus bulgaricus as the inoculum is also shown. As a result, when Lactobacillus sp, KPB-167 was used as a starter, the viscosity increased with fermentation and no whey separation was observed, and furthermore, no decrease in viscosity or whey separation occurred during refrigerated storage.
本発酵乳は良好な味と風味を持っていた。The fermented milk had good taste and flavor.
第1表
((至)強度:
→〉+〉←〉+〉−
例 2.(乳酸菌飲料)
ミルクホエー2Qを95℃で5分間加熱殺菌した後、3
0℃まで冷却する。種菌のラクトバチルスsp、KPB
−167培養液4o−を接種し、気相部をCO,ガスで
置換後、嫌気的条件下で発酵させた。発酵温度は30℃
とし、72時間後に発酵を終了した。発酵終了後の発酵
液は粘性を示す。ここで発酵液の一部を遠心分離(10
,00Orpm、 15分間)して得られる上澄液に、
同量の冷エタノールを添加して氷水中で静置すると多糖
ケフィランが沈澱する。ケフイランの含量は、200〜
300mg/ Q−発酵液であった。発酵液はそのまま
飲用してもよいが、例えばオレンジ果汁を10%(V/
V)添加すると、オレンジ風味のされやかな乳酸菌飲料
となる。Table 1 ((To) Strength: →〉+〉←〉+〉- Example 2. (Lactic acid bacteria drink) After heat sterilizing milk whey 2Q at 95℃ for 5 minutes,
Cool to 0°C. Inoculum Lactobacillus sp, KPB
-167 culture solution 4o- was inoculated, and after replacing the gas phase with CO and gas, fermentation was carried out under anaerobic conditions. Fermentation temperature is 30℃
Fermentation was completed after 72 hours. The fermented liquid after fermentation is viscous. Here, a part of the fermentation liquid is centrifuged (10
,00Orpm for 15 minutes) to the supernatant obtained.
When the same amount of cold ethanol is added and the mixture is left standing in ice water, the polysaccharide kefiran precipitates. The content of kefiran is 200~
300mg/Q-fermentation liquid. You can drink the fermented liquid as it is, but for example, add 10% (V/V) of orange juice.
V) When added, it becomes a refreshing lactic acid bacteria drink with an orange flavor.
[発明の効果]
本発明によれば、抗腫瘍活性等の生理活性を有する多糖
ケフィランを含有し、保健医療効果も期待される新規の
機能性発酵乳及び機能性乳酸菌飲料を簡単な工程で能率
的に製造することができる。また発酵乳の場合には含有
する多糖ケフィランの増粘効果によりホエー分離が全く
起こらず、保存期間中も安定した均質状態を保つことが
できる。[Effects of the Invention] According to the present invention, novel functional fermented milk and functional lactic acid bacteria beverages containing polysaccharide kefiran that have physiological activities such as antitumor activity and are expected to have health and medical effects can be efficiently produced in a simple process. It can be manufactured as follows. Furthermore, in the case of fermented milk, whey separation does not occur at all due to the thickening effect of the polysaccharide kefiran contained, and a stable homogeneous state can be maintained even during storage.
Claims (1)
て莢膜多糖生産菌ラクトバチルスsp.KPB−167
を使用することを特徴とする機能性発酵乳及び機能性乳
酸菌飲料の製法。 2、獣乳を原料とし、ラクトバチルスsp.KPB−1
67株を0.5〜5%(V/V)接種し、20〜45℃
で約20〜100時間発酵させることを特徴とする莢膜
多糖ケフィランを含有する発酵乳の製法。 3、獣乳ホエー、果汁、野菜ジュース等を原料とし、ラ
クトバチルスsp.KPB−167株を0.5〜5%(
V/V)接種し、20〜45℃で約20〜100時間発
酵させることを特徴とする莢膜多糖ケフィランを含有す
る乳酸菌飲料の製法。[Claims] 1. In the production of fermented milk and lactic acid bacteria beverages, capsular polysaccharide producing bacterium Lactobacillus sp. KPB-167
A method for producing functional fermented milk and a functional lactic acid bacteria beverage, characterized by using. 2. Using animal milk as a raw material, Lactobacillus sp. KPB-1
67 strains were inoculated at 0.5-5% (V/V) and incubated at 20-45°C.
A method for producing fermented milk containing capsular polysaccharide kefiran, which is characterized by fermenting for about 20 to 100 hours. 3. Using animal milk whey, fruit juice, vegetable juice, etc. as raw materials, Lactobacillus sp. KPB-167 strain 0.5-5% (
V/V) A method for producing a lactic acid bacteria beverage containing capsular polysaccharide kefiran, which comprises inoculating and fermenting at 20 to 45°C for about 20 to 100 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2221643A JPH04104761A (en) | 1990-08-23 | 1990-08-23 | Preparation of functional fermented milk and functional lactobacillus drink |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2221643A JPH04104761A (en) | 1990-08-23 | 1990-08-23 | Preparation of functional fermented milk and functional lactobacillus drink |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04104761A true JPH04104761A (en) | 1992-04-07 |
Family
ID=16769997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2221643A Pending JPH04104761A (en) | 1990-08-23 | 1990-08-23 | Preparation of functional fermented milk and functional lactobacillus drink |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04104761A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008541774A (en) * | 2005-06-10 | 2008-11-27 | コンパニ・ジェルベ・ダノン | High probiotic and low organic acid food |
JP2011109997A (en) * | 2009-11-30 | 2011-06-09 | Meiji Co Ltd | Method for producing fermented milk |
JP2014027943A (en) * | 2013-09-30 | 2014-02-13 | Meiji Co Ltd | Production method of fermented dairy product |
JP2017164003A (en) * | 2017-07-04 | 2017-09-21 | 株式会社明治 | Method for producing fermented milk |
-
1990
- 1990-08-23 JP JP2221643A patent/JPH04104761A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008541774A (en) * | 2005-06-10 | 2008-11-27 | コンパニ・ジェルベ・ダノン | High probiotic and low organic acid food |
JP2011109997A (en) * | 2009-11-30 | 2011-06-09 | Meiji Co Ltd | Method for producing fermented milk |
JP2014027943A (en) * | 2013-09-30 | 2014-02-13 | Meiji Co Ltd | Production method of fermented dairy product |
JP2017164003A (en) * | 2017-07-04 | 2017-09-21 | 株式会社明治 | Method for producing fermented milk |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4187321A (en) | Method for producing foods and drinks containing bifidobacteria | |
Wang et al. | Lactic acid fermentation of soybean milk | |
KR100471631B1 (en) | Bifidobacterium breve and fermented soymilk prepared with the same | |
CN101586087B (en) | Acid sensitivity lactobacillus bulgaricus strain and usage thereof | |
CN116590191B (en) | Lactobacillus plantarum and application thereof in preparation of dairy products | |
JPS6119220B2 (en) | ||
JP4693487B2 (en) | Method for producing lactic acid bacteria and tea beverage | |
CN115281247A (en) | Lactobacillus fermentum normal-temperature yogurt and preparation method thereof | |
JP6955808B1 (en) | How to make fermented honey | |
US4210672A (en) | Preparation of yogurt | |
JP2001112437A (en) | Production of food and drink containing bacteria of genus bifidobacterium | |
JPH04104761A (en) | Preparation of functional fermented milk and functional lactobacillus drink | |
JPH03210146A (en) | Production of functional fermented milk and functional lactic acid bacteria drink | |
JP2965281B2 (en) | Bifidobacterium culture and method for producing the same | |
CN113558192A (en) | Preparation process of novel synbiotics bean dreg fermented beverage | |
JPS6137049A (en) | Preparation of kefir | |
KR100501945B1 (en) | A method for preparation of fermentative drink by lactic acid fermentation of prickly pear and the product thereof | |
CN115943995B (en) | Lactobacillus reuteri normal-temperature milk beverage and preparation method thereof | |
RU2170023C2 (en) | Strain lactobacillus acidophilus a-91 used for preparing fermented-milk products, strain lactobacillus acidophilus h-91 used for preparing fermented-milk products, ferment for preparing fermented-milk products and preparation promoting body adaptation to unfavorable environment effects | |
KR960013120B1 (en) | Method for preparing fermented beverage using green tea | |
CN115997822B (en) | Lactobacillus reuteri normal-temperature yoghourt and preparation method thereof | |
JPH1175830A (en) | New bifidobacterium and its utilization | |
JP2627698B2 (en) | Culture containing live cells of Bifidobacterium breve and method for producing the same | |
KR790001822B1 (en) | Preparation of fermented milk containg viable bifidobacteria | |
KR0128715B1 (en) | Streptococcus mutant and process of fermented aloeberagel |